92
0.00%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥3.68bn
FY2017FY2026
Net income
¥88.4m
FY2017FY2026
Free cash flow
¥233.4m
FY2017FY2026
Shareholders' equity
¥5.86bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥3.68bn | ¥2.08bn | ¥2.13bn | ¥2.16bn | ¥1.95bn | ¥2.31bn | ¥2.67bn | ¥2.50bn | ¥2.37bn | ¥2.59bn |
| Gross profit | ¥1.09bn | ¥545.2m | ¥533.5m | ¥546.1m | ¥511.5m | ¥598.3m | ¥541.2m | ¥610.5m | ¥518.0m | ¥396.5m |
| Research and development | — | — | ¥4.0m | ¥2.0m | ¥6.0m | ¥1.0m | ¥12.0m | — | — | — |
| Operating income | ¥272.7m | ¥137.1m | ¥127.3m | ¥152.4m | ¥109.2m | ¥201.8m | ¥39.2m | ¥127.7m | ¥6.6m | −¥142.8m |
| Net income | ¥88.4m | ¥105.6m | ¥790.9m | ¥122.7m | ¥127.9m | ¥201.7m | −¥165.9m | ¥117.5m | −¥2.3m | −¥179.6m |
| Diluted earnings per share | 1.80 | 1.82 | 17.95 | 2.78 | 2.90 | 5.32 | -4.84 | 3.54 | -0.08 | -5.85 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥8.16bn | ¥5.74bn | ¥5.64bn | ¥5.40bn | ¥4.58bn | ¥4.71bn | ¥4.07bn | ¥4.06bn | ¥3.77bn | ¥3.70bn |
| Cash and short-term investments | ¥3.85bn | ¥2.58bn | ¥2.65bn | ¥1.39bn | ¥1.42bn | ¥2.25bn | ¥1.26bn | ¥1.28bn | ¥1.30bn | ¥1.55bn |
| Total liabilities | ¥1.62bn | ¥585.5m | ¥601.1m | ¥1.05bn | ¥879.6m | ¥1.15bn | ¥1.10bn | ¥1.26bn | ¥1.07bn | ¥1.01bn |
| Debt | ¥594.2m | ¥42.9m | ¥44.7m | ¥248.0m | ¥255.0m | ¥248.0m | ¥23.7m | ¥19.6m | ¥19.6m | ¥13.4m |
| Shareholders' equity | ¥5.86bn | ¥5.16bn | ¥5.04bn | ¥4.35bn | ¥3.70bn | ¥3.56bn | ¥2.97bn | ¥2.80bn | ¥2.70bn | ¥2.69bn |
| Shares outstanding | 49m | 58m | 44m | 44m | 44m | 38m | 34m | 33m | 31m | 31m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥270.3m | ¥4.3m | ¥483.6m | −¥3.6m | ¥300.6m | ¥435.3m | −¥379.1m | ¥1.4m | −¥51.1m | −¥372.6m |
| Capital spending | −¥36.9m | −¥11.0m | −¥194.6m | −¥15.7m | −¥97.2m | −¥109.2m | −¥3.4m | −¥14.9m | −¥9.9m | −¥8.5m |
| Free cash flow | ¥233.4m | −¥6.7m | ¥289.0m | −¥19.3m | ¥203.3m | ¥326.1m | −¥382.6m | −¥13.5m | −¥61.0m | −¥381.2m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥1.60bn | ¥1.45bn | ¥1.48bn | ¥479.1m | ¥270.0m | ¥797.4m | ¥468.0m | ¥425.0m |
| Gross profit | ¥360.0m | ¥482.9m | ¥387.0m | ¥157.6m | ¥63.4m | ¥256.4m | ¥122.5m | ¥102.6m |
| Operating income | ¥70.4m | ¥168.7m | ¥110.5m | ¥74.8m | −¥81.3m | ¥152.9m | ¥12.9m | ¥26.6m |
| Net income | ¥32.0m | ¥12.6m | ¥100.0m | ¥55.6m | −¥60.4m | ¥135.1m | ¥21.2m | −¥2.3m |
| Diluted earnings per share | 0.65 | 0.26 | 1.73 | 0.96 | -1.04 | 2.33 | 0.48 | -0.05 |
| Total assets | ¥8.70bn | ¥8.16bn | ¥8.02bn | ¥7.90bn | ¥5.58bn | ¥5.74bn | ¥5.51bn | ¥5.45bn |
| Cash and short-term investments | ¥3.68bn | ¥3.85bn | ¥3.57bn | ¥3.25bn | ¥2.44bn | ¥2.58bn | ¥2.50bn | ¥2.74bn |
| Debt | ¥366.0m | ¥594.2m | ¥96.0m | ¥489.5m | ¥25.7m | ¥42.9m | ¥29.7m | ¥45.8m |
| Shareholders' equity | ¥5.88bn | ¥5.86bn | ¥5.87bn | ¥5.72bn | ¥5.11bn | ¥5.16bn | ¥4.95bn | ¥4.93bn |
Financial ratios
Data as of 13 Oct 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2016 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 29.6% | 26.2% | 25.1% | 25.3% | 26.3% | 25.9% | — | — |
| Operating margin | 4.3% | 7.4% | 30.3% | 6.1% | 6.9% | 10.8% | — | — |
| Net margin | 2.4% | 5.1% | 37.2% | 5.7% | 6.6% | 8.7% | — | — |
| Return on equity | 1.5% | 2.0% | 15.7% | 2.8% | 3.5% | 5.7% | — | — |
| Return on assets | 1.1% | 1.8% | 14.0% | 2.3% | 2.8% | 4.3% | — | — |
| Free cash flow yield | 6.3% | 0.3% | 15.6% | 0.3% | 9.1% | 14.5% | — | — |
| Revenue growth | 76.9% | -2.1% | -1.4% | 10.9% | -15.7% | -13.4% | — | — |
| Earnings growth | -16.4% | -86.6% | 544.8% | -4.1% | -36.6% | -221.6% | — | — |
| Current ratio | 54.16x | 212.82x | 250.41x | 12.27x | 151.47x | 393.20x | — | — |
| Debt to equity | 0.10x | 0.01x | 0.01x | 0.06x | 0.07x | 0.07x | — | — |
| Equity ratio | 71.7% | 89.8% | 89.3% | 80.5% | 80.8% | 75.5% | — | — |
| Interest coverage | 51.04x | 228.41x | 613.54x | 110.69x | 107.96x | 300.07x | — | — |
| R&D as a share of sales | — | — | 0.2% | 0.1% | 0.3% | 0.0% | 0.4% | 1.1% |
| Buybacks as a share of market value | 15.1% | -31.5% | 0.0% | 0.0% | -16.2% | -10.5% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 19.5% | 9.8% | 7.2% |
| Operating income | 21.4% | 6.2% | — |
| Net income | -10.4% | -15.2% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 28.4% | 27.0% | 26.7% | 24.1% |
| Operating margin | 7.1% | 6.9% | 7.0% | 3.4% |
| Net margin | 3.4% | 11.0% | 10.0% | 3.9% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 53.5 | 80.6 | 4.3 | 32.3 | 37.9 | 18.6 | -21.7 | 29.4 | -1321.7 | -21.2 |
| Price to sales | 1.3 | 4.1 | 1.6 | 1.8 | 2.5 | 1.6 | 1.4 | 1.4 | 1.3 | 1.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 27 Mar 2015.
| FY2016 | FY2015 | FY2014 | |
|---|---|---|---|
| Paid in the year | 1.00 | 1.00 | 1.00 |
- 1-to-1 reverse split · 1 Oct 2006
- 10-to-1 reverse split · 2 Aug 2005
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.